{"id":"https://openalex.org/W3212780485","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.612","title":"612 Human ribonucleases act as potential plasma biomarkers for targeted therapy and immunotherapy in hepatocellular carcinoma","display_name":"612 Human ribonucleases act as potential plasma biomarkers for targeted therapy and immunotherapy in hepatocellular carcinoma","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3212780485","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.612","mag":"3212780485"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.612","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.612","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.612","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A642.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A642.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100386373","display_name":"Chunxiao Liu","orcid":"https://orcid.org/0000-0002-3675-3122","observed_orcids":["https://orcid.org/0000-0002-3675-3122"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chunxiao Liu","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014143044","display_name":"Zhengyu Zha","orcid":"https://orcid.org/0000-0002-8619-3661","observed_orcids":["https://orcid.org/0000-0002-8619-3661"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengyu Zha","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chenhao Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chenhao Zhou","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040450464","display_name":"Dihua Yu","orcid":"https://orcid.org/0000-0001-6231-9381","observed_orcids":["https://orcid.org/0000-0001-6231-9381"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dihua Yu","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076834432","display_name":"Mien\u2010Chie Hung","orcid":"https://orcid.org/0000-0003-4317-4740","observed_orcids":["https://orcid.org/0000-0003-4317-4740"]},"institutions":[{"id":"https://openalex.org/I184693016","display_name":"China Medical University","ror":"https://ror.org/00v408z34","country_code":"TW","type":"education","lineage":["https://openalex.org/I184693016"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Mien-Chie Hung","raw_affiliation_strings":["China Medical University, Taichung, Taiwan, Province of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"China Medical University, Taichung, Taiwan, Province of China","institution_ids":["https://openalex.org/I184693016"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020676867","display_name":"Ning Ren","orcid":"https://orcid.org/0000-0001-9776-2471","observed_orcids":["https://orcid.org/0000-0001-9776-2471"]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Ren","raw_affiliation_strings":["Fudan University, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fudan University, Shanghai, China","institution_ids":["https://openalex.org/I24943067"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A642","last_page":"A642"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8690000176429749},{"id":"https://openalex.org/keywords/ribonuclease","display_name":"ribonuclease","score":0.9350000023841858},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.8970000147819519},{"id":"https://openalex.org/keywords/ros1","display_name":"ROS1","score":0.7680000066757202},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/anti-pd-1-resistance","display_name":"anti-PD-1 resistance","score":0.859000027179718},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.9789999723434448},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.8230000138282776},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7300000190734863},{"id":"https://openalex.org/keywords/cold-to-hot-tumor-conversion","display_name":"cold-to-hot tumor conversion","score":0.6899999976158142},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.8040000200271606},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.8629999756813049},{"id":"https://openalex.org/keywords/orthotopic-mouse-model","display_name":"orthotopic mouse model","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7164292335510254},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6572989225387573},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.599421501159668},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.5973454713821411},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5905290246009827},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5842350125312805},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5697551965713501},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5238140225410461},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4779548645019531},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.43036291003227234},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4194117784500122},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3036803901195526},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2981390357017517},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2414001226425171},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.19323894381523132},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.14798730611801147},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.612","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.612","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.612","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A642.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:3f7ff5b3725e4f519e713ff6842342d9","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3f7ff5b3725e4f519e713ff6842342d9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.612","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.612","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.612","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A642.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3212780485.pdf","grobid_xml":"https://content.openalex.org/works/W3212780485.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3092608042","https://openalex.org/W4282924883","https://openalex.org/W4401510960","https://openalex.org/W2937238238","https://openalex.org/W7078797485","https://openalex.org/W7078800023","https://openalex.org/W4391781007","https://openalex.org/W3024416303","https://openalex.org/W4394001070","https://openalex.org/W7124572649"],"abstract_inverted_index":{"Background":[0],"Ribonucleases,":[1],"known":[2],"as":[3,14,62,160,310],"RNases,":[4],"are":[5,12,25,208,260,362],"secreted":[6],"in":[7,27,50,145,189,214,242,262,286,300,335],"the":[8,17,44,88,230,294,331],"circulatory":[9],"system":[10,20],"that":[11,152,183,256,303],"recognized":[13],"part":[15],"of":[16,48,73,91,138,168,174,192,206,217,245,249,267],"host":[18],"defense":[19],"against":[21],"pathogens.":[22],"Although":[23],"RNases":[24,49,59,96,156,257],"involved":[26],"multiple":[28],"physiologically":[29],"and":[30,41,46,76,97,106,141,163,185,195,270,348,357],"pathologically-relevant":[31],"cell":[32,36,39],"events,":[33],"including":[34],"cancer":[35,51],"growth,":[37],"stem":[38],"self-renewal":[40],"regenerative":[42],"capabilities,":[43],"regulation":[45],"function":[47,325],"therapy":[52,75,140],"remained":[53],"unclear.":[54],"Herein,":[55],"we":[56],"examined":[57],"whether":[58],"could":[60],"serve":[61,309],"plasma":[63,204,312],"biomarkers":[64],"to":[65,86,118,121,128,155,264,308,314,327,330,365],"stratify":[66,315],"hepatocellular":[67],"carcinoma":[68],"(HCC)":[69],"patients":[70,194,234,317,336],"for":[71,125,132,232,297,318],"combination":[72,133],"targeted":[74,139,320],"immunotherapy.":[77],"Methods":[78],"Two":[79],"independent":[80,167],"HCC":[81,112,146,193,221,246,268,287,301,316],"patient":[82,359],"cohorts":[83],"were":[84,101,115,123],"analyzed":[85],"evaluate":[87],"pathological":[89],"relevance":[90],"RNases.":[92],"The":[93,135],"association":[94],"between":[95],"receptor":[98],"tyrosine":[99],"kinases":[100],"validated":[102],"by":[103,229],"immunoprecipitation,":[104],"duolink":[105],"immunofluorescence":[107],"assays.":[108],"Tumor":[109],"specimens":[110],"from":[111,220],"patients,":[113,269],"who":[114],"categorized":[116],"according":[117],"clinical":[119,179],"response":[120],"nivolumab,":[122],"subjected":[124],"whole-transcriptome":[126],"sequencing":[127],"identify":[129],"critical":[130],"biomarker":[131,313],"therapy.":[134,321],"therapeutic":[136],"efficacy":[137,285],"immunotherapy":[142,284],"was":[143,227],"evaluated":[144],"orthotopic":[147,288],"models.":[148],"Results":[149],"We":[150,253],"discovered":[151],"RNase7,":[153],"belongs":[154],"superfamily":[157],"proteins,":[158],"acts":[159],"ROS1":[161,175,184,212,236,251],"ligand":[162],"triggers":[164],"oncogenic":[165,295],"transformation":[166],"its":[169],"catalytic":[170],"activities":[171],"via":[172],"activation":[173,248,281],"signaling.":[176],"In":[177],"addition,":[178],"data":[180],"analysis":[181],"revealed":[182],"RNase7":[186,207,299,304],"co-expression":[187],"occurs":[188],"approximately":[190,215],"30%":[191],"is":[196],"highly":[197],"correlated":[198,210],"with":[199,211,224,235,337,352],"poorer":[200],"survival.":[201],"Moreover,":[202],"high":[203],"levels":[205],"positively":[209],"phosphorylation":[213],"45%":[216],"tumor":[218,332,344,347],"tissues":[219],"patients.":[222],"Treatment":[223],"crizotinib,":[225],"which":[226,339],"approved":[228],"FDA":[231],"NSCLC":[233],"rearrangement,":[237],"induces":[238],"significant":[239],"anti-tumor":[240],"effect":[241],"mouse":[243],"models":[244],"harboring":[247],"RNase7/WT":[250],"axis.":[252],"also":[254],"found":[255],"family":[258],"proteins":[259],"upregulated":[261],"non-responders":[263],"nivolumab":[265],"treatment":[266],"enhances":[271],"anti-PD1":[272],"resistance":[273],"through":[274],"regulating":[275],"macrophage":[276],"polarization.":[277],"Blocking":[278],"RNase-induced":[279],"pathway":[280],"dramatically":[282],"enhanced":[283],"model.":[289],"Conclusions":[290],"Our":[291],"findings":[292],"identified":[293],"role":[296],"human":[298],"suggesting":[302],"exhibits":[305],"a":[306,311],"potential":[307],"anti-ROS1":[319],"Furthermore,":[322],"inhibiting":[323],"RNase":[324],"leads":[326],"substantial":[328],"changes":[329],"immune":[333],"profile":[334],"HCC,":[338],"may":[340],"convert":[341],"immunologically":[342],"\u201dcold\u201d":[343],"into":[345],"\u201dhot\u201d":[346],"be":[349],"effectively":[350],"combined":[351],"immunotherapeutic":[353],"agents.":[354],"Clinical":[355],"research":[356],"more":[358],"tissue":[360],"samples":[361],"under":[363],"evaluation":[364],"validate":[366],"these":[367],"findings.":[368]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}